Department of Obstetrics and Gynecology, Tianjin Medical University General Hospital, Tianjin, China.
Department of Obstetrics and Gynecology,Hohhot First Hospital, Hohhot, Inner Mongolia, China.
Bioengineered. 2021 Dec;12(1):8753-8767. doi: 10.1080/21655979.2021.1982230.
Literature reports that lncRNA KCNQ1OT1 is markedly up-regulated in cervical cancer (CC) tissues and cell lines, and KCNQ1OT1 can promote the proliferation and metastasis of CC cells. This current work was designed to investigate the molecular mechanism underlying the participation of KCNQ1OT1 in CC progression. Herein, RT-qPCR was utilized for determining the levels of KCNQ1OT1, miR-296-5p and HYOU1 in clinical tumor tissue specimens and CC cell lines. Then, starBase predicted the complementary binding sites of KCNQ1OT1 and miR-296-5p or miR-296-5p and HYOU1. Dual-luciferase reporter assay/RIP assay validated the interplays among KCNQ1OT1/miR-296-5p/HYOU1. In addition, CCK-8, wound healing and transwell assays were employed to assess the proliferative, migrative and invasive properties of CC cells. Moreover, nude mice xenograft model was established by subcutaneously injection with SiHa cells in order to validate the precise functions of KCNQ1OT1/miR-296-5p/HYOU1 axis in CC . Besides, Immunohistochemical staining examined Ki-67 expression in xenograft tumors and western blotting analysis detected expressions of MMP2/9 and Wnt/β-catenin signaling pathway in CC cells and xenograft tumors. Elevated KCNQ1OT1 and HYOU1 as well as reduced miR-296-5p were observed in clinical tumor tissue specimens and CC cell lines. Results revealed that upregulation of miR-296-5p counteracted the enhancing effects of overexpressed KCNQ1OT1 on the proliferative, migrative and invasive abilities of CC cells. Additionally, HYOU1 overexpression abolished the suppressing effects of silenced KCNQ1OT1 on the malignant behaviors of CC cells and tumor growth. To conclude, KCNQ1OT1 could aggravate the malignant behaviors of CC and facilitate tumor growth through modulating miR-296-5p/HYOU1 axis.
文献报道,lncRNA KCNQ1OT1 在宫颈癌(CC)组织和细胞系中明显上调,KCNQ1OT1 可促进 CC 细胞的增殖和转移。本研究旨在探讨 KCNQ1OT1 参与 CC 进展的分子机制。本研究采用 RT-qPCR 检测临床肿瘤组织标本和 CC 细胞系中 KCNQ1OT1、miR-296-5p 和 HYOU1 的水平。然后,starBase 预测了 KCNQ1OT1 与 miR-296-5p 或 miR-296-5p 与 HYOU1 的互补结合位点。双荧光素酶报告基因检测/RIP 实验验证了 KCNQ1OT1/miR-296-5p/HYOU1 之间的相互作用。此外,CCK-8、划痕愈合和 Transwell 实验用于评估 CC 细胞的增殖、迁移和侵袭特性。此外,通过皮下注射 SiHa 细胞建立裸鼠异种移植模型,以验证 KCNQ1OT1/miR-296-5p/HYOU1 轴在 CC 中的精确功能。此外,免疫组织化学染色检测异种移植瘤中 Ki-67 的表达,Western blot 分析检测 CC 细胞和异种移植瘤中 MMP2/9 和 Wnt/β-catenin 信号通路的表达。在临床肿瘤组织标本和 CC 细胞系中观察到 KCNQ1OT1 和 HYOU1 升高以及 miR-296-5p 降低。结果表明,上调 miR-296-5p 可拮抗过表达 KCNQ1OT1 对 CC 细胞增殖、迁移和侵袭能力的增强作用。此外,HYOU1 过表达消除了沉默 KCNQ1OT1 对 CC 细胞恶性行为和肿瘤生长的抑制作用。总之,KCNQ1OT1 通过调节 miR-296-5p/HYOU1 轴加重 CC 的恶性行为并促进肿瘤生长。